# | PDB (Resolution Å) |
Site # | Ligand | EC number | GO terms | UniProt | PubMed | Binding affinity |
---|---|---|---|---|---|---|---|---|
1 | 5t8k:A (1.95) | BS01 | NAD | 3.13.2.1 | GO:0000166 ... | Q5CPH1 | N/A | |
2 | 5t8k:A (1.95) | BS02 | ADE | 3.13.2.1 | GO:0000166 ... | Q5CPH1 | N/A | |
3 | 5t8k:A (1.95) | BS03 | NAD | 3.13.2.1 | GO:0000166 ... | Q5CPH1 | N/A | |
4 | 5t8k:B (1.95) | BS01 | NAD | 3.13.2.1 | GO:0000166 ... | Q5CPH1 | N/A | |
5 | 5t8k:B (1.95) | BS02 | ADE | 3.13.2.1 | GO:0000166 ... | Q5CPH1 | N/A | |
6 | 5t8k:B (1.95) | BS03 | NAD | 3.13.2.1 | GO:0000166 ... | Q5CPH1 | N/A | |
7 | 5t8k:C (1.95) | BS01 | NAD | 3.13.2.1 | GO:0000166 ... | Q5CPH1 | N/A | |
8 | 5t8k:C (1.95) | BS02 | NAD | 3.13.2.1 | GO:0000166 ... | Q5CPH1 | N/A | |
9 | 5t8k:C (1.95) | BS03 | ADE | 3.13.2.1 | GO:0000166 ... | Q5CPH1 | N/A | |
10 | 5t8k:D (1.95) | BS01 | NAD | 3.13.2.1 | GO:0000166 ... | Q5CPH1 | N/A | |
11 | 5t8k:D (1.95) | BS02 | NAD | 3.13.2.1 | GO:0000166 ... | Q5CPH1 | N/A | |
12 | 5t8k:D (1.95) | BS03 | ADE | 3.13.2.1 | GO:0000166 ... | Q5CPH1 | N/A |